Related Experiment Video
Updated: Feb 8, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
Long non-coding RNA LINC00222 regulates GSK3β activity and promotes cell apoptosis in lung adenocarcinoma
Hongyan Zhang1, Yuan Wang2, Jibin Lu3
1Department of Clinical Genetics, Shengjing Hospital of China Medical University, No.36 San Hao Street, Shenyang, 110004, PR China; Department of Thoracic surgery, Shengjing Hospital of China Medical University, No.36 San Hao Street, Shenyang, 110004, PR China.
Abstract:
Recent evidence indicates that long noncoding RNAs (lncRNAs) play a critical role in the regulating cellular processes such as differentiation, proliferation, metastasis and apoptosis. These lncRNAs are found to be dysregulated in a variety of cancers. However, the underlying mechanisms of lncRNAs action in lung adenocarcinoma remain unclear. We investigated expression of the lncRNA LINC00222 in 76 lung adenocarcinoma tissues and paired normal lung tissues and found that LINC00222 is downregulated in lung adenocarcinoma tissues. Enforced expression of LINC00222 significantly inhibited the proliferation, migration and invasive ability of lung adenocarcinoma cells, and also induced apoptosis. Furthermore, overexpression of LINC00222 enhanced the activity of glycogen synthase kinase-3β (GSK3β), which is a key element of the Wnt signaling pathway. Taken together, our findings suggest that LINC00222 acts as a tumor suppressor in lung adenocarcinoma and, therefore, could serve as a valuable prognostic biomarker and therapeutic target for lung adenocarcinoma patients.
Insights
Long noncoding RNA LINC00222 acts as a tumor suppressor in lung adenocarcinoma. Its downregulation promotes cancer cell proliferation and metastasis, suggesting it as a potential therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- Long noncoding RNAs (lncRNAs) are critical regulators of cellular processes.
- Dysregulation of lncRNAs is implicated in various cancers, including lung adenocarcinoma.
- Mechanisms of lncRNA action in lung adenocarcinoma are not fully understood.
Purpose of the Study:
- To investigate the role of lncRNA LINC00222 in lung adenocarcinoma.
- To explore LINC00222 as a potential biomarker and therapeutic target.
Main Methods:
- Quantitative analysis of LINC00222 expression in 76 lung adenocarcinoma tissues and paired normal tissues.
- In vitro experiments involving enforced expression of LINC00222 in lung adenocarcinoma cells.
- Assessment of cell proliferation, migration, invasion, and apoptosis.
- Analysis of glycogen synthase kinase-3β (GSK3β) activity and Wnt signaling pathway modulation.
Main Results:
- LINC00222 was found to be significantly downregulated in lung adenocarcinoma tissues.
- Enforced LINC00222 expression inhibited proliferation, migration, and invasion of lung adenocarcinoma cells.
- Overexpression of LINC00222 induced apoptosis in cancer cells.
- LINC00222 overexpression enhanced GSK3β activity, impacting the Wnt signaling pathway.
Conclusions:
- LINC00222 functions as a tumor suppressor in lung adenocarcinoma.
- LINC00222 holds potential as a prognostic biomarker for lung adenocarcinoma.
- LINC00222 represents a promising therapeutic target for lung adenocarcinoma treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
The Eukaryotic Promoter Region
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
RNA Polymerase II Accessory Proteins
Apoptosis

